The emerging role of statins in the treatment of heart failure

Journal of the American College of Cardiology

Volumn 47, Issue 2, 2006, Pages 342-344

  Ramasubbu, Kumudha ^a   Mann, Douglas L ^a,b  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b Faculty Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CERIVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 6; LIPOPROTEIN; PADGEM PROTEIN; SIMVASTATIN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR; VASCULAR ADHESION PROTEIN 1;

CLINICAL TRIAL; CYTOKINE PRODUCTION; DISEASE COURSE; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ENZYME ACTIVITY; HEART FAILURE; HUMAN; LIPOPROTEIN BLOOD LEVEL; NOTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 30344446286     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.10.031     Document Type: Editorial

References (25)

1. T.B. Horwich, W.R. MacLellan, G.C. Fonarow Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure J Am Coll Cardiol 43 2004 642 648
2. D. Mozaffarian, R. Nye, W.C. Levy Statin therapy is associated with lower mortality among patients with severe heart failure Am J Cardiol 93 2004 1124 1129
3. J. Kjekshus, T.R. Pedersen, A.G. Olsson, O. Faergeman, K. Pyorala The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease J Card Fail 3 1997 249 254
4. A. Hognestad, K. Dickstein, E. Myhre, S. Snapinn, J. Kjekshus Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocardial infarction associated with heart failure Am J Cardiol 93 2004 603 606
5. D. Tousoulis, C. Antoniades, E. Bosinakou Effects of atorvastatin on reactive hyperemia and inflammatory process in patients with congestive heart failure Atherosclerosis 178 2005 359 363
6. U. Laufs, S. Wassmann, S. Schackmann, C. Heeschen, M. Bohm, G. Nickenig Beneficial effects of statins in patients with non-ischemic heart failure Z Kardiol 93 2004 103 108
7. K. Node, M. Fujita, M. Kitakaze, M. Hori, J.K. Liao Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy Circulation 108 2003 839 843
8. M. Rauchhaus, A.L. Clark, W. Doehner The relationship between cholesterol and survival in patients with chronic heart failure J Am Coll Cardiol 42 2003 1933 1940
9. B.M. Richartz, B. Radovancevic, O.H. Frazier, W.K. Vaughn, H. Taegtmeyer Low serum cholesterol levels predict high perioperative mortality in patients supported by a left-ventricular assist system Cardiology 89 1998 184 188
10. T.B. Horwich, M.A. Hamilton, W.R. MacLellan, G.C. Fonarow Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure J Card Fail 8 2002 216 224
11. M. Rauchhaus, A.J. Coats, S.D. Anker The endotoxin-lipoprotein hypothesis Lancet 356 2000 930 933
12. W. Marz, R. Siekmeier, H.M. Muller, H. Wieland, W. Gross, H.G. Olbrich Effects of lovastatin and pravastatin on the survival of hamsters with inherited cardiomyopathy J Cardiovasc Pharmacol Ther 5 2000 275 279
13. S. Sola, M.Q.S. Mir, S. Lerakis, N. Tandon, B.V. Khan Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure J Am Coll Cardiol 47 2006 332 337
14. B.E. Bleske, J.M. Nicklas, R.L. Bard Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone following high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level J Am Coll Cardiol 47 2006 338 341
15. J.K. Liao Isoprenoids as mediators of the biological effects of statins J Clin Invest 110 2002 285 288
16. U. Laufs, J.K. Liao Isoprenoid metabolism and the pleiotropic effects of statins Curr Atheroscler Rep 5 2003 372 378
17. N. Shiga, K. Hirano, M. Hirano, J. Nishimura, H. Nawata, H. Kanaide Long-term inhibition of RhoA attenuates vascular contractility by enhancing endothelial NO production in an intact rabbit mesenteric artery Circ Res 96 2005 1014 1021
18. S. Hayashidani, H. Tsutsui, T. Shiomi Fluvastatin, a 3-hydroxy-3- methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction Circulation 105 2002 868 873
19. Y. Kureishi, Z. Luo, I. Shiojima The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals Nat Med 6 2000 1004 1010
20. L.G. Futterman, L. Lemberg Cardiac repair with autologous bone marrow stem cells Am J Crit Care 13 2004 512 518
21. K. Strehlow, S. Wassmann, M. Bohm, G. Nickenig Angiotensin AT1 receptor over-expression in hypercholesterolaemia Ann Med 32 2000 386 389
22. R.U. Pliquett, K.G. Cornish, J.D. Peuler, I.H. Zucker Simvastatin normalizes autonomic neural control in experimental heart failure Circulation 107 2003 2493 2498
23. R.U. Pliquett, K.G. Cornish, I.H. Zucker Statin therapy restores sympathovagal balance in experimental heart failure J Appl Physiol 95 2003 700 704
24. R. Seal, B. Pitt, P. Poole-Wilson, D. Sharma, D.C. Bradstreet, L.S. Ikeda Effects of HMG-CoA reductase inhibitors (statins) in patients with heart failure Eur J Heart Fail 2 2000 96
25. A. Hognestad, E. Myhre, V.-A. Sentralsykehus, S. Snapinn, J. Kjekshus Early lipid lowering and beta-receptor blockade during acute myocardial infarction reduce death and non-fatal infarction in heart failure patients (abstr) Circulation 104 2001 A762